Hitoshi Sugihara

Nippon Medical School — Japan

Medicine · Health Sciences

36h-index4.8kcitations163works13.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Growth Hormone and Insulin-like Growth Factors(53), Regulation of Appetite and Obesity(41), Pituitary Gland Disorders and Treatments(22), Pancreatic function and diabetes(21), Diabetes Treatment and Management(19)

Publications163 total

Impact of Graves’ hyperthyroidism treatment on lipid profiles and cholesterol dynamics: a prospective observational study
Therapeutic Advances in Endocrinology and Metabolism·2025· 1 citedOpen Access
Potential Utility of Circulating MicroRNA-483 as a Biomarker for IGF-II–Associated Non–Islet Cell Tumor Hypoglycemia
The Journal of Clinical Endocrinology & Metabolism·2024· 2 citedOpen Access
Ipragliflozin and sitagliptin differentially affect lipid and apolipoprotein profiles in type 2 diabetes: the SUCRE study
Cardiovascular Diabetology·2024· 36 citedOpen Access
Atypical Clinical Courses of Graves' Disease Confound Differential Diagnosis of Hyperthyroidism
Journal of Nippon Medical School·2023· 1 citedOpen Access
Exploring endocrinological pitfalls in pituitary surgery in the elderly
Heliyon·2023· 1 citedOpen Access
Concurrent IgG4-related hypophysitis and clinically nonfunctioning gonadotroph pituitary neuroendocrine tumor
BMC Endocrine Disorders·2023· 2 citedOpen Access
Early effects of insulin therapy on cholesterol synthesis and absorption markers in patients with type 2 diabetes
Clinical Nutrition Open Science·2023· 2 citedOpen Access
Fasting plasma glucose level-based formula for estimating starting daily dose in basal-bolus insulin therapy
Scientific Reports·2023· 1 citedOpen Access
Efficacy and safety of sitagliptin treatment in older adults with moderately controlled type 2 diabetes: the STREAM study
Scientific Reports·2023· 33 citedOpen Access
Antifibrotic effect and long‐term outcome of SGLT2 inhibitors in patients with NAFLD complicated by diabetes mellitus
Hepatology Communications·2022· 49 citedOpen Access
Analysis of Purine Metabolism to Elucidate the Pathogenesis of Acute Kidney Injury in Renal Hypouricemia
Biomedicines·2022· 17 citedOpen Access
HLA analysis of immune checkpoint inhibitor-induced and idiopathic isolated ACTH deficiency
Pituitary·2022· 13 cited
Effects of 1,5-anhydro-D-glucitol on insulin secretion both in in vitro and ex vivo pancreatic preparations
Journal of Pharmacological Sciences·2022· 2 citedOpen Access
Perioperative glycemic status is linked to postoperative complications in non-intensive care unit patients with type-2 diabetes: a retrospective study
Therapeutic Advances in Endocrinology and Metabolism·2022· 3 citedOpen Access
A case of pheochromocytoma associated with liver abscess and intestinal pseudo-obstruction
Therapeutic Advances in Endocrinology and Metabolism·2022· 1 citedOpen Access
Differences in glucose/lipid metabolic factors between obese/non-obese subjects with higher apnea-hypopnea index
2021
Risk Preferences, Rationality of Choices, and Willingness to Pay for Preventive Medicine in Patients with Graves’ Thyrotoxicosis
Patient Preference and Adherence·2021· 2 citedOpen Access
Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease
Scientific Reports·2021· 33 citedOpen Access
Prenatal Nicotine Exposure Induces Low Birthweight and Hyperinsulinemia in Male Rats
Frontiers in Endocrinology·2021· 10 citedOpen Access
Effects of trypsin inhibition on endocrine function in isolated rat pancreas
The FASEB Journal·2021
page 1 of 9Next →

Frequent Co-authors

Shinichi Oikawa(24), Jun Kamegai(23), Hideki Tamura(18), Ichiji Wakabayashi(18), Shinya Ishii(14), Shiro Minami(13), Mototsugu Nagao(13), Takako Shimizu(11), Tamotsu Shibasaki(7), Osamu Hasegawa(7), Yujin Shuto(6), Akira Asai(6), Naoya Emoto(5), Hisayuki Ohata(4), Izumi Fukuda(4), Asuka Otagiri(3), Hideki Kuriyama(3), Hiroshi Higuchi(3), Kenmei Okada(3), Taro Harada(3)